COMPARISON OF LONG-TERM EFFICACY BETWEEN THE BRECADD AND N+AVD REGIMENS IN ADVANCED-STAGE HODGKIN LYMPHOMA: A MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON OF THE HD21 AND SWOG S1826 TRIALS